Published in Reumatismo on October 02, 2006
The challenges and the promise of molecular targeted therapy in malignant gliomas. Neoplasia (2015) 0.96
Serum levels of three angiogenic factors in systemic lupus erythematosus and their clinical significance. Biomed Res Int (2014) 0.77
Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma. Blood (1999) 2.28
Bone marrow angiogenesis and progression in multiple myeloma. Br J Haematol (1994) 2.01
Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood (1999) 1.84
Bone marrow angiogenesis in multiple myeloma. Leukemia (2006) 1.47
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic. Lab Invest (1997) 1.39
Angiogenesis in rheumatoid arthritis. Histol Histopathol (2006) 1.39
Role of aquaporin-4 water channel in the development and integrity of the blood-brain barrier. J Cell Sci (2001) 1.28
C-reactive protein is independently associated with total body fat, central fat, and insulin resistance in adult women. Int J Obes Relat Metab Disord (2001) 1.23
Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene (2007) 1.18
Bortezomib as an antitumor agent. Curr Pharm Biotechnol (2006) 1.17
Lymphocytes and synovial fluid fibroblasts support osteoclastogenesis through RANKL, TNFalpha, and IL-7 in an in vitro model derived from human psoriatic arthritis. J Pathol (2007) 1.16
Microvessel overexpression of aquaporin 1 parallels bone marrow angiogenesis in patients with active multiple myeloma. Br J Haematol (2001) 1.16
Tissue distribution and membrane localization of aquaporin-9 water channel: evidence for sex-linked differences in liver. J Histochem Cytochem (2001) 1.12
Transferrin promotes endothelial cell migration and invasion: implication in cartilage neovascularization. J Cell Biol (1997) 1.11
Melanocyte tumor progression is associated with changes in angiogenesis and expression of the 67-kilodalton laminin receptor. Cancer (1993) 1.09
A model of study for human cancer: Spontaneous occurring tumors in dogs. Biological features and translation for new anticancer therapies. Crit Rev Oncol Hematol (2013) 1.05
Angiogenesis extent and macrophage density increase simultaneously with pathological progression in B-cell non-Hodgkin's lymphomas. Br J Cancer (1999) 1.04
Macrophages and tumor angiogenesis. Leukemia (2007) 1.04
alpha(v)beta(3) integrin engagement modulates cell adhesion, proliferation, and protease secretion in human lymphoid tumor cells. Exp Hematol (2001) 1.04
The mast cell: an active participant or an innocent bystander? Histol Histopathol (2004) 1.03
Macrophages in rheumatoid arthritis. Histol Histopathol (2007) 1.02
Interleukin-10 and interleukin-10 receptor in human osteoarthritic and healthy chondrocytes. Clin Exp Rheumatol (2001) 1.01
Bone marrow of patients with active multiple myeloma: angiogenesis and plasma cell adhesion molecules LFA-1, VLA-4, LAM-1, and CD44. Am J Hematol (1995) 1.01
I-309 binds to and activates endothelial cell functions and acts as an angiogenic molecule in vivo. Blood (2000) 1.01
A possible role of thymidine phosphorylase expression and 5-fluorouracil increased sensitivity in oropharyngeal cancer patients. J Cell Mol Med (2007) 0.99
Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives. J Biol Chem (2001) 0.99
Antiangiogenic activity of aplidine, a new agent of marine origin. Br J Cancer (2004) 0.97
Pentosan polysulfate as an inhibitor of extracellular HIV-1 Tat. J Biol Chem (2001) 0.97
Human lymphoblastoid cells produce extracellular matrix-degrading enzymes and induce endothelial cell proliferation, migration, morphogenesis, and angiogenesis. Int J Clin Lab Res (1998) 0.97
Characteristics of joint involvement and relationships with systemic inflammation in systemic sclerosis: results from the EULAR Scleroderma Trial and Research Group (EUSTAR) database. J Rheumatol (2010) 0.96
HOXB7 expression by myeloma cells regulates their pro-angiogenic properties in multiple myeloma patients. Leukemia (2010) 0.95
Tryptase-positive mast cells correlate positively with bone marrow angiogenesis in B-cell chronic lymphocytic leukemia. Leukemia (2003) 0.95
Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model. Diabetologia (2006) 0.94
Interleukin-27 inhibits pediatric B-acute lymphoblastic leukemia cell spreading in a preclinical model. Leukemia (2011) 0.93
Altered blood-brain barrier development in dystrophic MDX mice. Neuroscience (2004) 0.93
Order and disorder in the vascular network. Leukemia (2004) 0.93
Endothelin-1, a regulator of angiogenesis in the chick chorioallantoic membrane. J Vasc Res (2001) 0.93
Osteopontin is expressed and functional in human eosinophils. Allergy (2009) 0.92
Activation of endothelial cell mitogen activated protein kinase ERK(1/2) by extracellular HIV-1 Tat protein. Endothelium (2001) 0.92
Breast cancer cell line MDA-231 stimulates osteoclastogenesis and bone resorption in human osteoclasts. Biochem Biophys Res Commun (2000) 0.92
Progression of mycosis fungoides is associated with changes in angiogenesis and expression of the matrix metalloproteinases 2 and 9. Eur J Cancer (1997) 0.92
Bone marrow angiogenesis in patients with active multiple myeloma. Semin Oncol (2001) 0.92
Ultrastructural basis of the vessel wall differentiation in the chick embryo optic tectum. J Submicrosc Cytol (1985) 0.91
Inhibition of endothelial cell functions and of angiogenesis by the metastasis inhibitor NAMI-A. Br J Cancer (2002) 0.91
Vascular endothelial growth factor and its receptors in multiple myeloma. Leukemia (2003) 0.90
IgA nephropathy in systemic lupus erythematosus. Clin Exp Rheumatol (2007) 0.90
Complementary IL-23 and IL-27 anti-tumor activities cause strong inhibition of human follicular and diffuse large B-cell lymphoma growth in vivo. Leukemia (2011) 0.90
Angiogenesis in lipoma: An experimental study in the chick embryo chorioallantoic membrane. Int J Mol Med (1999) 0.90
The role of eosinophil major basic protein in angiogenesis. Allergy (2008) 0.90
Soluble decoy receptor 3 modulates the survival and formation of osteoclasts from multiple myeloma bone disease patients. Leukemia (2009) 0.89
Basic fibroblast growth factor overexpression in endothelial cells: an autocrine mechanism for angiogenesis and angioproliferative diseases. Cell Growth Differ (1996) 0.89
Targeting tumor lymphangiogenesis: an update. Curr Med Chem (2010) 0.89
Crosstalk between angiogenesis and lymphangiogenesis in tumor progression. Leukemia (2004) 0.89
Expression of survivin protein in pterygium and relationship with oxidative DNA damage. J Cell Mol Med (2008) 0.89
Mast cells and basophils: a potential link in promoting angiogenesis during allergic inflammation. Int Arch Allergy Immunol (2009) 0.89
Recombinant human erythropoietin induces intussusceptive microvascular growth in vivo. Leukemia (2004) 0.89
Sjögren's syndrome pathological neovascularization is regulated by VEGF-A-stimulated TACE-dependent crosstalk between VEGFR2 and NF-κB. Genes Immun (2012) 0.89
A novel role of the CX3CR1/CX3CL1 system in the cross-talk between chronic lymphocytic leukemia cells and tumor microenvironment. Leukemia (2011) 0.88
Angiogenesis and progression in human melanoma. Dermatol Res Pract (2010) 0.88
VEGF concentration from plasma-activated platelets rich correlates with microvascular density and grading in canine mast cell tumour spontaneous model. J Cell Mol Med (2008) 0.88
The thymus is a site of mast cell development in chicken embryos. Anat Embryol (Berl) (2004) 0.87
Vasculogenesis in the chick embryo optic tectum. Acta Anat (Basel) (1985) 0.86
Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells. Oncogene (2001) 0.86
Antiangiogenesis by cyclosporine. Exp Hematol (1998) 0.86
Clodronate inhibits angiogenesis in vitro and in vivo. Oncol Rep (2008) 0.86
Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process. Cancer Res (1999) 0.85
Proteolytic activity of human lymphoid tumor cells. Correlation with tumor progression. Dev Immunol (2000) 0.85
Contribution of endothelial cells to organogenesis: a modern reappraisal of an old Aristotelian concept. J Anat (2007) 0.85
Psoriatic arthritis and Klinefelter syndrome: case report. Clin Rheumatol (2006) 0.85
Angiogenesis in vasculitides. Clin Exp Rheumatol (2008) 0.84
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 correlate with upgrading and myometrial invasion in endometrial carcinoma. Eur J Clin Invest (1999) 0.84
Early alteration of synovial membrane in osteoarthrosis. Clin Rheumatol (1988) 0.84
Four proteins governing overangiogenic endothelial cell phenotype in patients with multiple myeloma are plausible therapeutic targets. Oncogene (2011) 0.84
On the use of thalidomide as an antiangiogenic agent in the treatment of multiple myeloma. Ann Hematol (2003) 0.83
Intermittent compressive load stimulates osteogenesis and improves osteocyte viability in bones cultured "in vitro". Clin Rheumatol (1996) 0.83
Osteocytes: central conductors of bone biology in normal and pathological conditions. Acta Physiol (Oxf) (2012) 0.83
Anti-angiogenic activity of the purine analog 6-thioguanine. Leukemia (2002) 0.83
Recent advances in targeted anti-vasculature therapy: the neuroblastoma model. Curr Drug Targets (2009) 0.83
Bone marrow angiogenesis and plasma cell angiogenic and invasive potential in patients with active multiple myeloma. Acta Haematol (2001) 0.83
The history of angiogenesis inhibitors. Leukemia (2007) 0.83
Angiogenesis extent and expression of matrix metalloproteinase-2 and -9 agree with progression of ovarian endometriomas. Eur J Clin Invest (2002) 0.83
Inhibition of fibroblast growth factor-2-induced vascular tumor formation by the acyclic nucleoside phosphonate cidofovir. Cancer Res (2001) 0.83
Inhibition of protein kinase C counteracts TNFalpha-induced intercellular adhesion molecule 1 expression and fluid phase endocytosis on brain microvascular endothelial cells. Brain Res (2000) 0.83
Cervical myelopathy caused by periodontoid synovial pannus in a patient with psoriatic arthritis: a case report. Clin Rheumatol (2006) 0.83
Podoplanin expression in tumor-free resection margins of oral squamous cell carcinomas: an immunohistochemical and fractal analysis study. Histol Histopathol (2010) 0.82
Ultrastructural study of the developing blood capillaries in the pineal gland of the domestic fowl. J Submicrosc Cytol (1983) 0.82
TNP-470 and recombinant human interferon-alpha2a inhibit angiogenesis synergistically. Br J Haematol (2000) 0.82
Echographic study of Tietze's syndrome. Clin Rheumatol (1991) 0.82
In vivo absence of synergism between fibroblast growth factor-2 and vascular endothelial growth factor. J Hematother Stem Cell Res (2001) 0.82
The role of monocytes-macrophages in vasculogenesis in multiple myeloma. Leukemia (2009) 0.82
VEGF and VEGFRs expression in oral squamous cell carcinoma. Rom J Morphol Embryol (2009) 0.82
[Apoptosis or programmed cell death: regulatory and pathophysiological mechanisms]. Ann Ital Med Int (1995) 0.81
Systemic sclerosis stimulates angiogenesis in the chick embryo chorioallantoic membrane. Clin Rheumatol (1998) 0.81
Low mast cell density in the human duodenal mucosa from chronic inflammatory duodenal bowel disorders is associated with defective villous architecture. Eur J Clin Invest (2003) 0.81
Macrophages and mast cells are involved in carotid plaque instability. Rom J Morphol Embryol (2011) 0.81
Successful treatment of avascular bone necrosis of the knee with neridronate: a case report. Rheumatol Int (2007) 0.81